Junlebao Dairy Group has launched its Nutrition Science Strategy, aiming to strengthen the science behind its products, as well as to identify novel functional ingredients.
Kirin’s first human milk oligosaccharides (HMOs) production plant has commenced operation and the company anticipates that half of the market will be dominated by China in the future.
FrieslandCampina said its 2’-fucosyllactose trademarked Aequival has been approved by Australia’s and New Zealand’s authorities for use in infant milk formula, and that it is on track in expanding its human milk oligosaccharide (HMO) portfolio.
Major nutrition company Health and Happiness (H&H Group) is pioneering research on how the right pairings of human milk oligosaccharides (HMOs) and probiotics – a novel category known as ‘HMObiotics’ – could bring about health benefits for consumers...
Infant formula companies are exploring new functional ingredients such as human milk oligosaccharides (HMOs), various milk bases such as goat milk and sheep milk and securing organic claims, according to experts who spoke at our Growth Asia Series 2021.
Taiwan has become the latest APAC region to approve the use of 2’-fucosyllactose (2’-FL) – a human milk oligosaccharide (HMO) – in nutrition products for infant and young children, with firms hopeful of further sector growth as more authorities permit...
